CA71716W1059
© Newsfile
20.01.2022
PHRX
LISTED
CSE
PharmaDrug Engages Octagon Media and Affiliated Wall Street Reporter for Investor Marketing Campaign
News Preview
Toronto, Ontario--(Newsfile Corp. - January 20, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, announces that it...
Themefolio
Profiler
Peergroup
© Newsfile
13.01.2022
PHRX
LISTED
CSE
PharmaDrug Announces Resignation of Director
News Preview
Toronto, Ontario--(Newsfile Corp. - January 13, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, announces that Mr. R...
Themefolio
Profiler
Peergroup
© Newsfile
13.12.2021
PHRX
LISTED
CSE
PharmaDrug Announces Addition of Dr. Cindy Hutnik, President of the Canadian Glaucoma Society to Their Scientific Advisory Board to Enhance Ongoing DMT Studies to Treat Glaucoma
News Preview
Toronto, Ontario--(Newsfile Corp. - December 13, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, pleased to announ...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Newsfile
30.11.2021
PHRX
LISTED
CSE
Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its Cepharanthine for Treatment of Mild to Moderate COVID-19 Infection
News Preview
Established alignment with FDA on the path forward for the development of PD-001, a patented enteric-coated formulation of cepharanthine, towards clinical studies for mild-moderate COVID-19 infectionMeeting response validates CMC package for PD-001 as an oral anti-viral to treat COVID-19 infectionPharmaDrug intends to pursue FDA Expedited Programs,...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
18.11.2021
PHRX
LISTED
CSE
PharmaDrug Provides Research Results and Initiates IND-Enabling Studies for Cepharanthine in the Treatment of Multiple Cancers
News Preview
Results of the 4 cancer types where cepharanthine provides exceptional potency and/or synergistic inhibitory effects when combined with standard of care (SoC) chemotherapy provides support for next development stageAdvancing Cepharanthine (PD-001) to IND-enabling efficacy studies to support potential FDA clinical studies in 2022Toronto, Ontario--(N...
Themefolio
Profiler
Peergroup
© Newsfile
05.11.2021
PHRX
LISTED
CSE
PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases
News Preview
PharmaDrug narrows list of candidate tryptamine molecules for the treatment of primary open angle glaucoma (PAOG)Terasaki Institute receives PharmaDrug's two candidate DMT analogue molecules Terasaki Institute, initiates supportive IND-enabling mechanism of action studies to evaluate potency and kinetics of PharmaDrug's DMT analoguesToronto, Ontari...
Themefolio
Profiler
Peergroup
© Newsfile
01.11.2021
PHRX
LISTED
CSE
PharmaDrug Expands Product Offering to Prepare for Potential Adult Use Market in Germany
News Preview
Toronto, Ontario--(Newsfile Corp. - November 1, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleas...
Themefolio
Profiler
Peergroup
© Newsfile
20.10.2021
PHRX
LISTED
CSE
PharmaDrug Commences Trading on the OTCQB Market in the United States
News Preview
Toronto, Ontario--(Newsfile Corp. - October 20, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleas...
Themefolio
Profiler
Peergroup
© Newsfile
15.10.2021
PHRX
LISTED
CSE
PharmaDrug Announces Positive Research Results for Cepharanthine in the Treatment of Multiple Cancers When Used Alone and in Combination with Chemotherapy
News Preview
Cepharanthine reproducibly demonstrates potential as a monotherapy in treating multiple cancers with unsatisfactory treatment optionsIdentified 4 cancer types where cepharanthine provides additive or synergistic inhibitory effects when combined with standard of care (SoC) chemotherapyContinued focus on esophageal cancer as most highly responsive ca...
Themefolio
Profiler
Peergroup
© Newsfile
28.09.2021
PHRX
LISTED
CSE
PharmaDrug Announces pre-IND Meeting Request Granted by FDA for Oral Antiviral Drug Cepharanthine for the Treatment of COVID-19 Infection
News Preview
Toronto, Ontario--(Newsfile Corp. - September 28, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to...
Themefolio
Profiler
Peergroup
© Newsfile
23.09.2021
PHRX
LISTED
CSE
PharmaDrug's Super Smart Launches Slim MycoWeRx Brand of Functional Mushrooms
News Preview
Toronto, Ontario--(Newsfile Corp. - September 23, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is p...
Themefolio
Profiler
Peergroup
© Newsfile
30.08.2021
PHRX
LISTED
CSE
Biotech Veteran David Kideckel Joins the Board of PharmaDrug
News Preview
Toronto, Ontario--(Newsfile Corp. - August 30, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is ple...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
25.08.2021
PHRX
LISTED
CSE
PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study
News Preview
Toronto, Ontario--(Newsfile Corp. - August 25, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is ple...
Themefolio
Profiler
Peergroup
© Newsfile
06.08.2021
PHRX
LISTED
CSE
PharmaDrug Announces Appointment of Auditor
News Preview
Toronto, Ontario--(Newsfile Corp. - August 6, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, today a...
Themefolio
Profiler
Peergroup
© Newsfile
05.08.2021
PHRX
LISTED
CSE
PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease
News Preview
Unlocking the potential of psychedelics, including DMT, and other tryptamines to treat the significant unmet medical needs of glaucoma patientsPartnering with world-renowned research institution brings validated drug delivery expertise in novel, controlled drug-release technologiesToronto, Ontario--(Newsfile Corp. - August 5, 2021) - PharmaDrug Inc...
Themefolio
Profiler
Peergroup
© Newsfile
28.07.2021
PHRX
LISTED
CSE
Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers
News Preview
Validates Cepharanthine's potential in treating various cancers with unsatisfactory treatment optionsPositions Cepharanthine's 'pipeline in a pill' strategy focusing on esophageal, colorectal, liver and skin cancersAdvance to FDA IND-enabling studies to support human clinical studiesToronto, Ontario--(Newsfile Corp. - July 28, 2021) - PharmaDrug In...
Themefolio
Profiler
Peergroup
© Newsfile
23.07.2021
PHRX
LISTED
CSE
PharmaDrug Announces Stock Ticker Symbol Change to (CSE: PHRX)
News Preview
Toronto, Ontario--(Newsfile Corp. - July 23, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleas...
Themefolio
Profiler
Peergroup
© Newsfile
14.07.2021
PHRX
LISTED
CSE
PharmaDrug Reports Positive Preclinical Study Results of Cepharanthine to Treat Cancers
News Preview
Toronto, Ontario--(Newsfile Corp. - July 14, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleas...
Themefolio
Profiler
Peergroup
© Newsfile
12.07.2021
PHRX
LISTED
CSE
PharmaDrug Announces Change of Auditor
News Preview
Toronto, Ontario--(Newsfile Corp. - July 12, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, today an...
Themefolio
Profiler
Peergroup
© Newsfile
22.06.2021
PHRX
LISTED
CSE
PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Infectious Diseases Including COVID-19
News Preview
Toronto, Ontario--(Newsfile Corp. - June 22, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleas...
Themefolio
Profiler
Peergroup
© Newsfile
07.06.2021
PHRX
LISTED
CSE
Pharmadrug's Supersmart Launches Psilocybin Online Retail Platform in the Netherlands
News Preview
Toronto, Ontario--(Newsfile Corp. - June 7, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased...
Themefolio
Profiler
Peergroup
© Newsfile
17.05.2021
PHRX
LISTED
CSE
PharmaDrug's Super Smart Launches Online Retail Platform in the United States
News Preview
Toronto, Ontario--(Newsfile Corp. - May 17, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased...
Themefolio
Profiler
Peergroup
© Newsfile
14.05.2021
PHRX
LISTED
CSE
PharmaDrug Signs Supply Agreement with European Cannabis Extractor for Medical Grade THC Oil to Be Sold Under PharmaDrug Brand
News Preview
Toronto, Ontario--(Newsfile Corp. - May 14, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased...
Themefolio
Profiler
Peergroup
© Newsfile
13.05.2021
PHRX
LISTED
CSE
PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and Grants Him Options and Promotes Him to Chief Scientific Officer for All of Pharmadrug
News Preview
Toronto, Ontario--(Newsfile Corp. - May 13, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is...
Themefolio
Profiler
Peergroup
© Newsfile
06.05.2021
PHRX
LISTED
CSE
PharmaDrug Initiates Preclinical Study of Cepharanthine to Both Broaden Its Cancer Scope and to Streamline Its Strategy for Esophageal Cancer
News Preview
Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased...
Themefolio
Profiler
Peergroup
© Newsfile
28.04.2021
PHRX
LISTED
CSE
PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the Prevention of Ischemia-Reperfusion Injury from Organ Transplantation
News Preview
Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is plea...
Themefolio
Profiler
Peergroup
© Newsfile
20.04.2021
PHRX
LISTED
CSE
PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Rare Cancers and Infectious Diseases
News Preview
Toronto, Ontario--(Newsfile Corp. - April 20, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is plea...
Themefolio
Profiler
Peergroup
© Newsfile
16.03.2021
PHRX
LISTED
CSE
Pharmadrug Initiates DMT Research Activities via Collaboration with the University of Michigan for Foundational DMT Research Study
News Preview
Toronto, Ontario--(Newsfile Corp. - March 16, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, i...
Themefolio
Profiler
Peergroup
© Newsfile
12.03.2021
PHRX
LISTED
CSE
PharmaDrug Provides Update on Its Annual General Meeting
News Preview
Toronto, Ontario--(Newsfile Corp. - March 12, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), will hold its Annual General Meeting ("AGM" or "Meeting") on March 25, 2021 at 10:00AM Eastern Standard Time at its corporate office, Suite 2905 - 77 King Street West, Toronto. The call-in number for the Meeting is 1...
Themefolio
Profiler
Peergroup
© Newsfile
09.03.2021
PHRX
LISTED
CSE
PharmaDrug Announces Drug-Repurposing Expert Moshe Rogosnitzky Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board
News Preview
Toronto, Ontario--(Newsfile Corp. - March 9, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") wholly-owned subsidiary, Sairiyo Therapeutics Inc. ("Sairiyo"), a biotechnology company focused on the research and development of Cepharanthine, a repurposed and reformulated naturally-derived compound for the potentia...
Themefolio
Profiler
Peergroup
© Newsfile
04.03.2021
PHRX
LISTED
CSE
PharmaDrug Announces World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board
News Preview
Toronto, Ontario--(Newsfile Corp. - March 4, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") wholly-owned subsidiary, Sariyo Therapeutics Inc. ("Sairiyo"), a biotechnology company focused on the research and development of Cepharanthine, a repurposed and reformulated naturally-derived compound for the pot...
Themefolio
Profiler
Peergroup
© Newsfile
25.02.2021
PHRX
LISTED
CSE
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics Strategy
News Preview
Toronto, Ontario--(Newsfile Corp. - February 25, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is p...
Themefolio
Profiler
Peergroup
© Newsfile
11.02.2021
PHRX
LISTED
CSE
PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke
News Preview
Toronto, Ontario--(Newsfile Corp. - February 11, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances, natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased t...
Themefolio
Profiler
Peergroup
© Newsfile
08.02.2021
PHRX
LISTED
CSE
PharmaDrug Appoints World-Renowned DMT Expert Dr. Steven A. Barker to Its Scientific Advisory Board for Psychedelic Pharmaceuticals
News Preview
Toronto, Ontario--(Newsfile Corp. - February 8, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pl...
Themefolio
Profiler
Peergroup
© Newsfile
05.02.2021
PHRX
LISTED
CSE
PharmaDrug Grants Stock Options
News Preview
Toronto, Ontario--(Newsfile Corp. - February 5, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") announces the grant of stock options to directors, officers and consultants to purchase 5,200,000 common shares of the Company, exercisable at $0.085 per share at any time on or before February 4, 2026. The grants a...
Themefolio
Profiler
Peergroup
© Newsfile
04.02.2021
PHRX
LISTED
CSE
PharmaDrug Signs Supply Agreement with Global Cannabis Supplier and Provides Update on German Operations and Balance Sheet Improvements
News Preview
Toronto, Ontario--(Newsfile Corp. - February 4, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") has entered into a supply agreement (the "Supply Agreement") on January 4, 2021, with a Canadian based multinational cannabis company for EU-GMP certified medical cannabis. The supply is already registered and...
Themefolio
Profiler
Peergroup
© Newsfile
02.02.2021
PHRX
LISTED
CSE
PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.
News Preview
Toronto, Ontario--(Newsfile Corp. - February 2, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, today announced that...
Themefolio
Profiler
Peergroup
© Newsfile
25.01.2021
PHRX
LISTED
CSE
PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer
News Preview
Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, today announced that...
Themefolio
Profiler
Peergroup
© Newsfile
12.01.2021
PHRX
LISTED
CSE
PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.
News Preview
Toronto, Ontario--(Newsfile Corp. - January 12, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is please...
Themefolio
Profiler
Peergroup
© Newsfile
15.12.2020
PHRX
LISTED
CSE
Pharmadrug Provides Corporate Update and Balance Sheet Status
News Preview
Toronto, Ontario--(Newsfile Corp. - December 15, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to provide an update to the status of its balance sheet following the recent general equity market upswing and the increase in PharmaDrug's volume and share price appreciation. Recent market activity has...
Themefolio
Profiler
Peergroup
© Newsfile
30.11.2020
PHRX
LISTED
CSE
Pharmadrug Shortlists Prime Amsterdam Locations for State-of-the-art Smart Shop Superstore and Expands Scope of E-Commerce Platform with Essential Good
News Preview
Toronto, Ontario--(Newsfile Corp. - November 30, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") will be launching its new Slim Winkel brand in the next couple of weeks. The Company's work with Es...
Themefolio
Profiler
Peergroup
© Newsfile
23.11.2020
PHRX
LISTED
CSE
PharmaDrug Positions for Eurozone Psychedelic Distribution as Germany Begins Psilocybin Depression Study
News Preview
Toronto, Ontario--(Newsfile Corp. - November 23, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") applauds the recent approval by Germany's Federal Institute of Drugs and Medical Devices (BfArM) of a study examining the Efficacy and Safety of Psilocybin in Treatment-Resistant Depression. This marks the first psi...
Themefolio
Profiler
Peergroup
© Newsfile
13.10.2020
PHRX
LISTED
CSE
PharmaDrug's Super Smart Begins to Work with Essential Good to Develop Its Brand and Build an Innovative Online Retail Platform
News Preview
Toronto, Ontario--(Newsfile Corp. - October 13, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has begun to work with Essential Good LLC ("Essential Good") to develop its Slim Winkel brand a...
Themefolio
Profiler
Peergroup
© Newsfile
28.09.2020
PHRX
LISTED
CSE
PharmaDrug's Super Smart Reaches Distribution Agreement with Red Light Holland for iMicrodose Packs and for Red Light Holland to Build out an iMicrodose Media Information Centre (iMIC) with Super Smart's Location in Tiel, The Netherlands
News Preview
Toronto, Ontario--(Newsfile Corp. - September 28, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC PINK: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has reached a distribution agreement with Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX...
Themefolio
Profiler
Peergroup
© Newsfile
21.09.2020
PHRX
LISTED
CSE
Pharmadrug Inc. Closes Transaction to Acquire First Smart Shop in the Netherlands and Now Initiates Major Push to Acquire Best of Breed High Traffic Locations
News Preview
Toronto, Ontario--(Newsfile Corp. - September 21, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has closed the transaction to acquire the retail establishment specializing in the sale of psyched...
Themefolio
Profiler
Peergroup
© Newsfile
01.09.2020
PHRX
LISTED
CSE
Pharmadrug Enters into Employment Agreements with Executive Team and Grants Stock Options and Also Provides Update on Super Smart Store Acquisition
News Preview
Toronto, Ontario--(Newsfile Corp. - September 1, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that it has entered into employment agreements with Daniel Cohen, the Company's Chairman and CEO, and Harry Resin, President of PharmaDrug's wholly-owned subsidiary Interrobang Ltd. d/b/a Super Sma...
Themefolio
Profiler
Peergroup
© Newsfile
11.08.2020
PHRX
LISTED
CSE
PharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the Netherlands
News Preview
Toronto, Ontario--(Newsfile Corp. - August 11, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has entered into a definitive agreement to acquire (the "Acquisition") a retail establishm...
Themefolio
Profiler
Peergroup
© Newsfile
22.07.2020
PHRX
LISTED
CSE
Pharmadrug Inc. Signs Cannabis Supply Agreement with Eve & Co
News Preview
Toronto, Ontario--(Newsfile Corp. - July 22, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that it has entered into a supply agreement (the "Supply Agreement") with Natural MedCo Ltd.("NMC"), a Canadian Licensed Producer of medical cannabis and a wholly-owned subsidiary of Eve & Co...
Themefolio
Profiler
Peergroup
© Newsfile
17.07.2020
PHRX
LISTED
CSE
PharmaDrug Inc. Repays Amounts Owing Under Bridge Loan and Advisory Agreement, Completes Previously Announced Debt Restructuring and Provides Financial Update
News Preview
Toronto, Ontario--(Newsfile Corp. - July 17, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that it has repaid amounts owing by the Company to the lender (inclusive of interest and fees) pursuant to a bridge loan (the "Bridge Loan") and amounts owing to a financial advisor under an advisory...
Themefolio
Profiler
Peergroup
© Newsfile
16.07.2020
PHRX
LISTED
CSE
Pharmadrug Inc. Completes Strategic Mutual Investment with Red Light Holland Corp.
News Preview
Toronto, Ontario--(Newsfile Corp. - July 16, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that it has completed the share exchange transasction with Red Light Holland Corp. ("RLH") (CSE: TRIP) (FSE: 4YX), an Ontario-based corporation positioning itself to engage in the production, growth a...
Themefolio
Profiler
Peergroup
© Newsfile
15.07.2020
PHRX
LISTED
CSE
PharmaDrug Inc. Proposes a Strategic Mutual Investment with Red Light Holland Corp.
News Preview
Toronto, Ontario--(Newsfile Corp. - July 15, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that it has entered into a share exchange agreement with Red Light Holland Corp. (CSE: TRIP) ("RLH"), an Ontario-based corporation positioning itself to engage in the production, growth and sale o...
Themefolio
Profiler
Peergroup
© Newsfile
09.07.2020
PHRX
LISTED
CSE
Pharmadrug Inc. Provides Update on Debt Restructuring
News Preview
Toronto, Ontario--(Newsfile Corp. - July 9, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that further to its press release dated May 20, 2020, that it proposes to complete a restructuring of certain of its outstanding indebtedness.Under the terms of the restructuring the outstanding $4...
Themefolio
Profiler
Peergroup
© Newsfile
29.06.2020
PHRX
LISTED
CSE
Pharmadrug Inc. Announces Postponement of Executive Compensation Disclosure
News Preview
Toronto, Ontario--(Newsfile Corp. - June 29, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") announced that it will be relying on the temporary blanket relief provided by the Canadian Securities Administrators to postpone filing of its executive compensation disclosure required under applicable securities laws unti...
Themefolio
Profiler
Peergroup
© Newsfile
19.06.2020
PHRX
LISTED
CSE
Top Canadian Entreprenuer Michael Forbes Joins the Board of Directors of PharmaDrug Inc.
News Preview
Toronto, Ontario--(Newsfile Corp. - June 19, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that Michael Forbes will be joining the board effective immediately.Over the course of 16 years, Michael has created and operated a chain of pharmacies throughout BC and Alberta. Michael's innovative n...
Themefolio
Profiler
Peergroup
© Newsfile
15.06.2020
PHRX
LISTED
CSE
Pharmadrug Inc. Completes Acquisition of Super Smart with a New Added Focus on the Psychedelic Market
News Preview
Toronto, Ontario--(Newsfile Corp. - June 15, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug" or the "Company") is pleased to announce that it has completed its previously announced (see press release dated May 25, 2020) acquisition of all of the issued and outstanding shares of privately-held Interrobang Ltd. (doing business as Super...
Themefolio
Profiler
Peergroup
© Newsfile
10.06.2020
PHRX
LISTED
CSE
PharmaDrug Receives Conditional Approval for Grant of Options
News Preview
Toronto, Ontario--(Newsfile Corp. - June 10, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "PharmaDrug") is pleased to announce that it has received conditional approval from the Canadian Securities Exchange for the previously announced (see press release dated June 2, 2020) grant of 5,000,000 options (the "Options") to Terry B...
Themefolio
Profiler
Peergroup
© Newsfile
09.06.2020
PHRX
LISTED
CSE
PharmaDrug Announces Application for Management Cease Trade Order
News Preview
Toronto, Ontario--(Newsfile Corp. - June 8, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "PharmaDrug") announced today that it has made an application to the Ontario Securities Commission to approve a temporary management cease trade order ("MCTO") under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), whi...
Themefolio
Profiler
Peergroup
© Newsfile
03.06.2020
PHRX
LISTED
CSE
PharmaDrug Provides Update on Annual and Interim Financial Statements
News Preview
Toronto, Ontario--(Newsfile Corp. - June 3, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "PharmaDrug") announces, further to its April 24, 2020 news release in relation to the timing of the filing of its year-end financial statements, the Company still expects to file such documents on or prior to June 15, 2020.The Comp...
Themefolio
Profiler
Peergroup
© Newsfile
02.06.2020
PHRX
LISTED
CSE
Pharmadrug Appoints Cannabis Icon Terry Booth as Chairman of Advisory Board
News Preview
Toronto, Ontario--(Newsfile Corp. - June 2, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "PharmaDrug") is pleased to announce that it has appointed global cannabis industry pioneer and founder of Aurora Cannabis Inc. (NYSE: ACB) ("Aurora"), Terry Booth, as the Chairman of its advisory board focussing on the Company's...
Themefolio
Profiler
Peergroup
© Newsfile
29.05.2020
PHRX
LISTED
CSE
Pharmadrug Inc. Unveils Roadmap for European Psilocybin Business
News Preview
Toronto, Ontario--(Newsfile Corp. - May 29, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") has released an overview of their plans to enter the European psilocybin marketplace via the pending closing of the acquisition of Interrobang LTD. currently doing business as Super Smart (herein referred to as "Super Smart")...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
